Weight Loss Interventions for Obesity
1 other identifier
interventional
50
1 country
1
Brief Summary
Numerous barriers towards weight management among Singaporeans with obesity exists, which involves environmental and self-regulation factors (i.e. motivation and hunger). Hence, the provision of healthy ketogenic ready-to-eat meals may be a potential solution to facilitate initial weight loss through increasing motivation while reducing appetite and hunger levels among these individuals. Therefore, this study will investigate the effect of healthy ketogenic ready-to-eat meals with mHealth nutrition application versus healthy ketogenic diet (without meal provision) with the mHealth nutrition app to facilitate weight loss and improve metabolic outcomes among individuals with obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2023
CompletedFirst Submitted
Initial submission to the registry
August 28, 2023
CompletedFirst Posted
Study publicly available on registry
September 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedSeptember 5, 2023
August 1, 2023
7 months
August 28, 2023
August 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Body weight
Weight changes post-intervention
1 month, 3 months, 6 months
Secondary Outcomes (11)
Blood pressure
3 months, 6 months
Hemoglobin A1c
3 months, 6 months
Fasting blood glucose
3 months, 6 months
Total cholesterol
3 months, 6 months
Low-density lipoprotein cholesterol
3 months, 6 months
- +6 more secondary outcomes
Study Arms (2)
Healthy Ketogenic Ready-To-Eat (HK-RTE) Meals
EXPERIMENTALParticipants in the HK-RTE group (n=25) will be provided with the Healthfull meals for lunch and dinner in the first month. They will be advised to take these meals as part of a healthy ketogenic diet, with a maximum of 50g total net carbohydrates daily. Participants will receive nutrition education conducted by dietitians over the course of 6 months (total of 5 dietary workshops covering topics such as ketogenic dietary advice and self-monitoring habits). Participants will also receive health coaching via the Nutritionist Buddy (nBuddy) mobile application to facilitate monitoring of diet intake, physical activity and weight throughout the 6 months study period.
Healthy Ketogenic Diet (HKD)
ACTIVE COMPARATORParticipants in the reference group will be instructed to follow a Healthy Ketogenic Diet (n = 25), with a maximum of 50g total net carbohydrates daily. Similar to the experimental group, participants will receive nutrition education conducted by dietitians over the course of 6 months (total of 5 dietary workshops such as ketogenic dietary advice and self-monitoring habit). Participants will also receive health coaching via the Nutritionist Buddy (nBuddy) mobile application to facilitate monitoring of diet intake, physical activity and weight throughout the 6 months study period.
Interventions
Participants will be provided nutrition education via 5 dietary workshops focusing on a healthy ketogenic diet. In addition, HK-RTE meals will be provided to participants as a form of meal replacement for lunch and dinner over 1 month. Participants will be expected to follow a healthy ketogenic diet thereafter.
Participants will receive nutrition education via 5 dietary workshops focusing on a healthy ketogenic diet, without the provision of HK-RTE meals.
Eligibility Criteria
You may qualify if:
- Aged 21 to 75 years old
- Body Mass Index \>= 27.5kg/m2
- Own a smartphone
- Literacy in English
- NUH staff
You may not qualify if:
- Intention of pregnancy; Pregnancy; Lactating individuals
- Type 1 Diabetes Mellitus or Type 2 Diabetes Mellitus on insulin treatment
- Untreated Endocrinopathy (e.g., hyper/hypothyroidism)
- Advanced kidney disease
- Abnormal liver function test assessed at screening
- Heart diseases
- Severe cognitive or psychiatric disabilities/disorders (e.g., eating disorders, depression)
- Active malignancies
- Taking medications that affect appetite or induce weight loss; previous or plans for bariatric surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital
Singapore, 119074, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- It is not feasible to apply blinding to the study design due to the nature of the intervention
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2023
First Posted
September 5, 2023
Study Start
July 21, 2023
Primary Completion
March 1, 2024
Study Completion
May 1, 2024
Last Updated
September 5, 2023
Record last verified: 2023-08